Rocket Pharmaceuticals Inc (RCKT)
23.40
-0.26
(-1.10%)
USD |
NASDAQ |
May 16, 16:00
23.41
+0.01
(+0.04%)
After-Hours: 20:00
Rocket Pharmaceuticals Cash from Investing (Quarterly): 35.03M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 35.03M |
| December 31, 2023 | -140.80M |
| September 30, 2023 | 48.25M |
| June 30, 2023 | 31.21M |
| March 31, 2023 | -36.72M |
| December 31, 2022 | -108.58M |
| September 30, 2022 | 23.46M |
| June 30, 2022 | 78.79M |
| March 31, 2022 | -63.00M |
| December 31, 2021 | 16.86M |
| September 30, 2021 | -18.19M |
| June 30, 2021 | 49.35M |
| March 31, 2021 | -29.17M |
| December 31, 2020 | -54.46M |
| September 30, 2020 | -64.19M |
| June 30, 2020 | -5.435M |
| March 31, 2020 | 27.50M |
| December 31, 2019 | 23.51M |
| September 30, 2019 | 35.18M |
| June 30, 2019 | -126.88M |
| March 31, 2019 | 29.18M |
| Date | Value |
|---|---|
| December 31, 2018 | 19.05M |
| September 30, 2018 | -2.985M |
| June 30, 2018 | -107.41M |
| March 31, 2018 | 86.08M |
| December 31, 2017 | 75.74M |
| September 30, 2017 | -0.001M |
| June 30, 2017 | -0.598M |
| March 31, 2017 | -0.131M |
| December 31, 2016 | -42.28M |
| September 30, 2016 | 4.931M |
| June 30, 2016 | -16.37M |
| March 31, 2016 | -12.34M |
| December 31, 2015 | -2.24M |
| September 30, 2015 | -29.40M |
| June 30, 2015 | -0.03M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-140.80M
Minimum
Dec 2023
78.79M
Maximum
Jun 2022
-13.91M
Average
5.714M
Median
Cash from Investing (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | -3.775M |
| ADMA Biologics Inc | -2.362M |
| Geron Corp | 34.21M |
| Madrigal Pharmaceuticals Inc | 98.05M |
| United Therapeutics Corp | 735.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -56.86M |
| Cash from Financing (Quarterly) | 1.184M |
| Free Cash Flow | -209.70M |
| Free Cash Flow Per Share (Quarterly) | -0.6295 |
| Free Cash Flow Yield | -10.24% |